XOMA Royalty Non-Current Deferred Revenue (Quarterly) Insights

XOMA Royalty Corp. (XOMA)

26.66 -3.19 (-10.69%) USD | NASDAQ | Jan 12, 16:00

26.66 0.00 (0.00%) After-Hours: 18:51

View Non-Current Deferred Revenue (Quarterly) for XOMA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Mirum Pharmaceuticals, Inc.	--
Recursion Pharmaceuticals, Inc.	Upgrade
Rezolute, Inc.	--
Vistagen Therapeutics, Inc.	Upgrade
Zevra Therapeutics, Inc.	--